Bagsværd, Denmark

Niels Behrendt


Average Co-Inventor Count = 10.5

ph-index = 4

Forward Citations = 40(Granted Patents)


Location History:

  • Bagsv.ae butted.rd, DK (1999)
  • Bagsvaerd, DK (1996 - 2000)
  • Bagsværd, DK (2001)

Company Filing History:


Years Active: 1996-2001

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Niels Behrendt: Innovator in Cancer Research

Introduction

Niels Behrendt is a notable inventor based in Bagsværd, Denmark. He has made significant contributions to the field of cancer research, holding a total of 4 patents. His work primarily focuses on the mechanisms of plasminogen activation and its implications in cancer biology.

Latest Patents

Behrendt's latest patents include innovative methods and compositions related to the urokinase-type plasminogen activator receptor. One of his patents describes how the activation of plasminogen to plasmin can be inhibited by preventing the binding of a receptor binding form of urokinase-type plasminogen activator to its receptor in mammals. This inhibition is crucial for preventing the conversion of plasminogen into plasmin, which is a key process in cancer metastasis. Another patent involves the development of antibodies that target the urokinase plasminogen activator receptor (u-PAR). These antibodies can be utilized in various diagnostic and therapeutic applications, including immunohistochemical detection of u-PAR in cancer cells.

Career Highlights

Throughout his career, Niels Behrendt has worked with prominent organizations such as Cancerforskningsfondet Af 1989 and Cancerforskningsfonden Af 1989. His research has significantly advanced the understanding of cancer biology and therapeutic strategies.

Collaborations

Behrendt has collaborated with notable colleagues in the field, including Vincent Ellis and Charles Pyke. Their combined expertise has contributed to the development of innovative solutions in cancer research.

Conclusion

Niels Behrendt's contributions to cancer research through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence the understanding and treatment of cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…